Wolverine Trading
ATRS

Wolverine Trading’s Antares Pharma, Inc. ATRS Stock Holding History

Wolverine Trading’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,600
Closed -$63K – 5556
2019
Q4 		$63K Buy
+13,600
New +$55.7K ﹤0.01% 4406
2019
Q3 		– Sell
-15,400
Closed -$51K – 5252
2019
Q2 		$51K Sell
15,400
-33,800
-69% -$97.8K ﹤0.01% 4188
2019
Q1 		$149K Buy
49,200
+16,600
+51% +$53.8K ﹤0.01% 3999
2018
Q4 		$86K Buy
32,600
+7,300
+29% +$24K ﹤0.01% 4031
2018
Q3 		$85K Buy
+25,300
New +$78.1K ﹤0.01% 4592
2017
Q2 		– Sell
-25,000
Closed -$69K – 5196
2017
Q1 		$69K Buy
+25,000
New +$60.1K ﹤0.01% 3927
2016
Q4 		– Sell
-15,200
Closed -$27K – 5399
2016
Q3 		$27K Buy
+15,200
New +$18.6K ﹤0.01% 4483

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Wolverine Trading's ATRS Position: Q2 2021 in Review

Wolverine Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 17,895 shares — an estimated $72K sold.

Wolverine Trading first reported a position in ATRS in Q1 2017 and held it in 16 quarters. The position peaked at $239K in Q3 2019. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Wolverine Trading reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 17,895 Antares Pharma, Inc. shares in Q2 2021, an estimated $72K.
  • Wolverine Trading first reported a position in Antares Pharma, Inc. in Q1 2017 and held it in 16 quarters.
  • Wolverine Trading's Antares Pharma, Inc. position peaked at $239K in Q3 2019.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.